Optimizing Management of Tumor Lysis Syndrome in Adults with Hematologic Malignancies-Reference-Cited by-同舟云学术

Optimizing Management of Tumor Lysis Syndrome in Adults with Hematologic Malignancies

Published:2005-04 Issue:3 Volume:2 Page:159-166
ISSN:1543-2912
Container-title:Supportive Cancer Therapy
language:en
Short-container-title:Supportive Cancer Therapy

Author:

Michallet Anne-Sophie,Tartas Sophie,Coiffier Bertrand

Publisher

Elsevier BV

Subject

Cancer Research,Pharmacology,Oncology

Reference40 articles.

1. Cairo MS, Arikian S, Casciano R, et al. Uric acid (UA) is a significant and independent prognostic factor in the development of tumour lysis syndrome (TLS) and renal complications in patients with hematological malignancies admitted for chemotherapy. Blood 2002; 99 (Abstract #4670).

2. Recombinant urate oxidase for prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignancies;Ribeiro;Clin Lymphoma,2003

3. Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries;Annemans;Leuk Lymphoma,2003

4. Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia;Cheson;J Clin Oncol,1998

5. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma;Pui;J Clin Oncol,2001

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Síndrome de lisis tumoral;Medicina Clínica;2019-05

2. Tumour lysis syndrome;Medicina Clínica (English Edition);2019-05

3. Update on the prevention and treatment of tumor lysis syndrome;Journal of Onco-Nephrology;2019-02

4. Risk-based management strategy and outcomes of tumor lysis syndrome in children with leukemia/lymphoma: Analysis from a resource-limited setting;Pediatric Blood & Cancer;2018-08-12

5. Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies;Journal of Hematology & Oncology;2012-12